| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6822468 | Schizophrenia Research | 2017 | 6 Pages |
Abstract
The authors recommend using standardized diagnostic interviews to screen patients for eligibility criteria and using the PANSS according to the author's recommendations and the proposed guidelines. Uniform criteria to define remission, response and exacerbation are recommended for clinical trials examining the efficacy and safety of antipsychotic drugs in schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ahmed Aboraya, Stefan Leucht, Henry A. Nasrallah, Myrto Samara, Josep Maria Haro, Ahmed Elshazly, Masood Zangeneh,